Resultado da Busca
Há 4 dias · [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Colorectal Cancer Market size & share revenue was valued at ...
Há 3 dias · POLE and POLD1 proofreading deficiency (POLE/D1pd) define a rare subtype of ultramutated metastatic colorectal cancer (mCRC; over 100 mut/Mb). Disease-specific data about the activity and efficacy of immune checkpoint inhibitors (ICIs) in POLE/D1pd mCRC are lacking and it is unknown whether outcomes may be different from mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H ...
Há 1 dia · Purpose Several studies have observed that some stage III colorectal cancer (CRC) patients cannot benefit from standard adjuvant chemotherapy. However, there is no unified screening standard to date. Methods Consecutive patients with pathologically confirmed colon adenocarcinoma treated in 3 centers between January 2016 and December 2018 were included. Patients were divided into four groups ...
Há 4 dias · Adenocarcinoma, câncer no intestino, colón retal Resumo. Tumores intestinais em cães podem apresentar baixa incidência, porém costumam ter comportamento infiltrativo e agressivo. Por isso é necessária realização de um bom estadiamento clínico para o melhor planejamento terapêutico e cirúrgico.
Há 6 horas · Results from Ph1a/1b Analyses of TTX-080, a First-in-Class HLA-G Antagonist, in Combination with Cetuximab in Patients with Metastatic Colorectal Cancer and Head and Neck Squamous Cell Carcinoma
Há 4 dias · Young Stage IV Colorectal Cancer Patients More Likely to Receive and Benefit from Aggressive Treatments, Study Finds. New research has found that patients with stage IV early-onset colorectal cancer — defined as individuals under the age of 50 — are more likely to receive chemotherapy and surgery compared to older patients.
Há 5 dias · The British Journal of Cancer is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research. It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention,diagnosis and treatment. None. ISSN. 0007-0920.
